Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis

• Main Authors: Ramaswami U (Author), Beck M (Author), Hughes D (Author), Kampmann C (Author), Botha J (Author), Pintos-Morell G (Author), West ML (Author), Niu DM (Author), Nicholls K (Author), Giugliani R (Author)
• Format: Book
• Published: Dove Medical Press, 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Uma Ramaswami,1 Michael Beck,2 Derralynn Hughes,1 Christoph Kampmann,2 Jaco Botha,3 Guillem Pintos-Morell,4 Michael L West,5 Dau-Ming Niu,6 Kathy Nicholls,7,8 Roberto Giugliani9 On behalf of the FOS Study Group 1Royal Free London NHS Foundation Trust, Lysosomal Disorders Unit, Inst...